Company / Interest Expense per Share
Adaptive Biotechnologies Corp Interest Expense per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.08
FY2025
5-year range
$0.03 / $0.10
FY2022-FY2025
Trend
-0.1%
vs FY2024
Sector context
#26 of 43
Health Care
What the data says
At $0.08, Adaptive Biotechnologies Corp's interest expense per share ranks #18 of 43 in the Health Care sector. Improved from $0.10 to $0.08 over the past 2 years.
Based on SEC 10-K filings.
0.08 in FY2025 with a 3-year CAGR of +38.5%.
Improved from $0.10 to $0.08 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +38.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#18 of 43 in Health CareTop 40% of 43This company $0.08 Sector average $9.80
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 0.1% year-over-year.
- Ranks #26 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | -0.1% |
| FY2024 | $0.08 | -17.2% |
| FY2023 | $0.10 | +221.7% |
| FY2022 | $0.03 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026